Mass Spectrometry Proteomics for Biomarker Discovery

See why Sapient is a preferred proteomics CRO for scientists seeking deep proteome coverage, high analytical specificity, and highly scalable throughput.

The proteomics CRO of choice for bespoke services to accelerate studies.

Proteins are dynamic indicators of health, disease, and drug response. Sapient leverages our high throughput mass spectrometry approaches to profile protein biomarkers with a breadth and depth of measure, rapidly capturing thousands of proteins per sample, across thousands of samples.

Our method is scalable to your coverage and throughput demands, and achieves high analytical specificity by annotating proteins and post-translational modifications (PTMs) via direct peptide sequencing.

Choose from:

Sapient /Core/ Discovery

Assays >4,000 circulating proteins in plasma and serum, including PTMs, with rapid turnaround.

Sapient /HT/ Discovery

Our fastest high throughput method, ideal for large-scale studies seeking to analyze thousands of samples per week.

Sapient /Deep/ Discovery

Optimized for cell- and tissue-based studies when the deepest proteome coverage is required.

All methods interrogate PTMs including phosphorylation, acetylation, methylation, and ubiquitination

Supported by an advanced biocomputational framework for analysis of proteomics data and other integrated omics, preclinical, and clinical datasets, we deliver actionable insights to elucidate disease mechanisms, subtype diseases, and ultimately improve the precision and efficacy of therapies.

Download the Fact Sheet

Explore how our discovery proteomics services can deliver unique insights to accelerate your studies.

"*" indicates required fields


Ready to discover more?

Connect with our scientists to discuss our discovery proteomics services or the biological questions you want to answer. We’re here to help you gain actionable insight at any phase of development.